Clinical Trial: Feasibility Study of a Chatbot AI-Driven Preliminary Screening System for Hereditary Cancer Syndromes

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901543) titled 'Feasibility Study of a Chatbot AI-Driven Preliminary Screening System for Hereditary Cancer Syndromes' on Oct. 22.

Brief Summary: This study aims to assess the feasibility of implementing an AI-based hereditary cancer preliminary screening system that has already been developed. This validation cohort will consist of healthy individuals and cancer patients, including those already suspected to be at risk of hereditary conditions.

Study Start Date: July 21

Study Type: OBSERVATIONAL

Condition: Hereditary Cancer Syndromes

Intervention: OTHER: Hereditary cancer preliminary screening chatbot

Patients will answer questions through ...